BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 16941075)

  • 1. A pharmacokinetic study of intra-CSF administered encapsulated cytarabine (DepoCyt) for the treatment of neoplastic meningitis in patients with leukemia, lymphoma, or solid tumors as part of a phase III study.
    Phuphanich S; Maria B; Braeckman R; Chamberlain M
    J Neurooncol; 2007 Jan; 81(2):201-8. PubMed ID: 16941075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.
    Glantz MJ; Jaeckle KA; Chamberlain MC; Phuphanich S; Recht L; Swinnen LJ; Maria B; LaFollette S; Schumann GB; Cole BF; Howell SB
    Clin Cancer Res; 1999 Nov; 5(11):3394-402. PubMed ID: 10589750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open label trial of sustained-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitis.
    Jaeckle KA; Batchelor T; O'Day SJ; Phuphanich S; New P; Lesser G; Cohn A; Gilbert M; Aiken R; Heros D; Rogers L; Wong E; Fulton D; Gutheil JC; Baidas S; Kennedy JM; Mason W; Moots P; Russell C; Swinnen LJ; Howell SB
    J Neurooncol; 2002 May; 57(3):231-9. PubMed ID: 12125986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of drugs formulated with DepoFoam: a sustained release drug delivery system for parenteral administration using multivesicular liposome technology.
    Angst MS; Drover DR
    Clin Pharmacokinet; 2006; 45(12):1153-76. PubMed ID: 17112293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology of encapsulated sustained-release cytarabine.
    Murry DJ; Blaney SM
    Ann Pharmacother; 2000 Oct; 34(10):1173-8. PubMed ID: 11054987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis.
    Bomgaars L; Geyer JR; Franklin J; Dahl G; Park J; Winick NJ; Klenke R; Berg SL; Blaney SM
    J Clin Oncol; 2004 Oct; 22(19):3916-21. PubMed ID: 15459213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis.
    Glantz MJ; LaFollette S; Jaeckle KA; Shapiro W; Swinnen L; Rozental JR; Phuphanich S; Rogers LR; Gutheil JC; Batchelor T; Lyter D; Chamberlain M; Maria BL; Schiffer C; Bashir R; Thomas D; Cowens W; Howell SB
    J Clin Oncol; 1999 Oct; 17(10):3110-6. PubMed ID: 10506606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal Fluid Drug Concentrations and Clinical Outcome of Patients with Neoplastic Meningitis Treated with Liposomal Cytarabine.
    Bohn JP; Reinstadler V; Pall G; Stockhammer G; Steurer M; Oberacher H; Wolf D
    Eur J Drug Metab Pharmacokinet; 2019 Dec; 44(6):845-851. PubMed ID: 31435852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current treatment approaches for neoplastic meningitis: nursing management of patients receiving intrathecal DepoCyt.
    Craig C
    Oncol Nurs Forum; 2000 Sep; 27(8):1225-30; quiz 1231-2. PubMed ID: 11013903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and safety of intrathecal liposomal cytarabine in children aged <3 years.
    Peyrl A; Sauermann R; Traunmueller F; Azizi AA; Gruber-Olipitz M; Gupper A; Slavc I
    Clin Pharmacokinet; 2009; 48(4):265-71. PubMed ID: 19492871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomal cytarabine (DepoCyte) for the treatment of neoplastic meningitis.
    Rueda Domínguez A; Olmos Hidalgo D; Viciana Garrido R; Torres Sánchez E
    Clin Transl Oncol; 2005 Jul; 7(6):232-8. PubMed ID: 16131445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended CSF cytarabine exposure following intrathecal administration of DTC 101.
    Kim S; Chatelut E; Kim JC; Howell SB; Cates C; Kormanik PA; Chamberlain MC
    J Clin Oncol; 1993 Nov; 11(11):2186-93. PubMed ID: 8229133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality-of-life-adjusted survival comparison of sustained-release cytosine arabinoside versus intrathecal methotrexate for treatment of solid tumor neoplastic meningitis.
    Cole BF; Glantz MJ; Jaeckle KA; Chamberlain MC; Mackowiak JI
    Cancer; 2003 Jun; 97(12):3053-60. PubMed ID: 12784341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomal cytarabine for leukemic and lymphomatous meningitis: recent developments.
    Benesch M; Urban C
    Expert Opin Pharmacother; 2008 Feb; 9(2):301-9. PubMed ID: 18201152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotoxicity of intra-CSF liposomal cytarabine (DepoCyt) administered for the treatment of leptomeningeal metastases: a retrospective case series.
    Chamberlain MC
    J Neurooncol; 2012 Aug; 109(1):143-8. PubMed ID: 22539243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between the expression of the genes encoding the key enzymes for cytarabine metabolism and the pharmacokinetics of cytarabine in the treatment of childhood acute leukemia with high-dose cytarabine].
    Xie XT; Jiang SY; Li BS; Yang LL
    Zhonghua Er Ke Za Zhi; 2008 Apr; 46(4):276-80. PubMed ID: 19099730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of intralumbar DTC-101 for the treatment of leptomeningeal metastases.
    Chamberlain MC; Kormanik P; Howell SB; Kim S
    Arch Neurol; 1995 Sep; 52(9):912-7. PubMed ID: 7661730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose idarubicin in combination with Ara-C in patients with relapsed or refractory acute lymphoblastic leukemia: a pharmacokinetic and clinical study.
    Tedeschi A; Montillo M; Strocchi E; Cafro AM; Tresoldi E; Intropido L; Nichelatti M; Marbello L; Baratè C; Camaggi CM; Morra E
    Cancer Chemother Pharmacol; 2007 May; 59(6):771-9. PubMed ID: 17256136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Phase I study of intrathecal chemotherapy with NS-101 for leptomeningeal carcinomatosis in Japan].
    Nakagawa H; Tamura M; Fukushima Y; Majima S; Yamada K
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1799-805. PubMed ID: 18030013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial and pharmacokinetic evaluation of cytosine arabinoside for leptomeningeal metastases from breast cancer.
    Esteva FJ; Soh LT; Holmes FA; Plunkett W; Meyers CA; Forman AD; Hortobagyi GN
    Cancer Chemother Pharmacol; 2000; 46(5):382-6. PubMed ID: 11127942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.